Search results
19 kwi 2022 · For this guidance document, ESBL-E will refer to presumed or confirmed ESBL-producing E. coli, K. pneumoniae, K. oxytoca, or P. mirabilis. Treatment recommendations for ESBL-E infections listed below assume that in vitro activity of preferred and alternative antibiotics has been demonstrated.
Recent hospitalization and high Wagner score on admission were noted to be independent predictors of infection with ESBL-producing bacteria, serving as further guidance for the choice of empirical antibiotic therapy.
1 kwi 2013 · Carbapenems should be reserved for treatment of infections likely to be caused by multi-antibiotic–resistant gram-negatives (e.g., when extended-spectrum β-lactamase [ESBL]–producing organisms are of particular concern).
European Society of Cardiology. Guidelines. Clinical Practice Guidelines. 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases. Full Text. Access full text on Journal website. Back to ESC Clinical Practice Guidelines resources. Your access to the latest cardiovascular news, science, tools and resources.
31 sie 2019 · 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Francesco Cosentino.
15 lis 2023 · This guideline gives recommendations on CV risk stratification as well as on screening, diagnosis, and treatment of CVD in patients with diabetes.
Abstract. Aims: Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure.
